Carmell Therapeutics to Launch Phase III Study of Bone Healing Accelerant

Carmell Therapeutics is planning to launch a Phase III clinical study for Bone Healing Accelerant, its first Plasma-based Bioactive Material (PBM) product/indication, designed to treat bone fractures while reducing complications, infections and duration of care.

PBM technology uses pooled plasma to create products which accelerate the healing...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us